Podcasts about Yale New Haven Health System

Howie and Harlan are joined by Deborah Rhodes, a Yale internist and the chief quality officer for Yale Medicine and Yale New Haven Health System. They discuss how she helped develop a better approach to scanning for breast cancer in women with dense breast tissue, and the obstacles to wide adoption. Harlan reports on the Trump administration's plan to slash indirect support for research; Howie explains the potential consequences of cuts to Medicaid. Links: Flu and Research Cuts “Weekly US Influenza Surveillance Report: Key Updates for Week 5, ending February 1, 2025” “This Is One of the Worst Flu Seasons in Decades” “Court Pause on Trump Cuts to Medical Research Funds Is Expanded Nationwide” “What National Institutes of Health funding cuts could mean for U.S. universities” Breast-Cancer Screening TED Talk by Deborah Rhodes: “A test that finds 3x more breast tumors, and why it's not available to you” Deborah Rhodes: “A Survey of Patient Experience During Molecular Breast Imaging” Mayo Clinic Breast Clinic: “How To Decide What To Do If You Have Dense Breasts On Mammogram” Deborah Rhodes: “Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts” Cleveland Clinic: Fibroglandular Density Are You Dense? “Evaluation of a Clinical Decision Support System for Imaging Requests” Medicaid “House Republicans release budget plan, with trillions in tax and spending cuts” “Trump's return puts Medicaid on the chopping block” “House GOP releases budget calling for trillions in cuts to taxes and spending” “Red states likely to feel the pain of Medicaid cuts” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Deborah Rhodes, a Yale internist and the chief quality officer for Yale Medicine and Yale New Haven Health System. They discuss how she helped develop a better approach to scanning for breast cancer in women with dense breast tissue, and the obstacles to wide adoption. Harlan reports on the Trump administration's plan to slash indirect support for research; Howie explains the potential consequences of cuts to Medicaid. Links: Flu and Research Cuts “Weekly US Influenza Surveillance Report: Key Updates for Week 5, ending February 1, 2025” “This Is One of the Worst Flu Seasons in Decades” “Court Pause on Trump Cuts to Medical Research Funds Is Expanded Nationwide” “What National Institutes of Health funding cuts could mean for U.S. universities” Breast-Cancer Screening TED Talk by Deborah Rhodes: “A test that finds 3x more breast tumors, and why it's not available to you” Deborah Rhodes: “A Survey of Patient Experience During Molecular Breast Imaging” Mayo Clinic Breast Clinic: “How To Decide What To Do If You Have Dense Breasts On Mammogram” Deborah Rhodes: “Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts” Cleveland Clinic: Fibroglandular Density Are You Dense? “Evaluation of a Clinical Decision Support System for Imaging Requests” Medicaid “House Republicans release budget plan, with trillions in tax and spending cuts” “Trump's return puts Medicaid on the chopping block” “House GOP releases budget calling for trillions in cuts to taxes and spending” “Red states likely to feel the pain of Medicaid cuts” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Capital is the cornerstone of healthcare infrastructure, and building large-scale projects without it is impossible.  Joining us today is Gail W. Kosyla, Executive Vice President and CFO at Yale New Haven Health System, to explore the intersection of healthcare, finance, and infrastructure. With over 38 years of experience, Gail has navigated the complexities of mergers, capital allocation, and strategic planning in a not-for-profit healthcare model, overseeing $6 billion in annual operations.  In this engaging discussion, Gail shares how her team balances immediate needs with long-term investments, including a billion-dollar neurosciences tower project adapted in the wake of the pandemic. She also reflects on the challenges of fostering innovation while maintaining access and quality in a system under financial pressure.  Gail's career path offers valuable lessons for leaders across industries. Her focus on mentorship, collaboration, and lifelong learning underscores the importance of shared knowledge and diverse perspectives in tackling today's challenges.  Tune in for a fresh perspective on leadership in complex, dynamic systems! Key Points From This Episode:•   Balancing quality care delivery with financial sustainability in nonprofit healthcare.•   Unpacking the role of mergers and acquisitions in the healthcare industry.•   How leadership makes decisions that balance core services and new growth opportunities.•   Gail's experiences as a woman in finance and healthcare and how it's shaped her leadership.•   The future of healthcare real estate, including supplementing ownership of core facilities.•   Examining the challenges and opportunities of managing large-scale projects.•   The need for strategic planning and investment in technology and growth. Quotes:“[As a non-profit] we don't exist to make a profit, but we need to make a profit to be able to fund important projects, to fund growth, and to have that security net of care for our community.” — Gail W. Kosyla “Everyone should be involved in finance. We've all got to be stewards of our resources – I just consider myself the shepherd of that. It's up to all of our people – down to every employee in the organization of just being good stewards of our resources.” — Gail W. Kosyla  “Building those connections and having safe spaces to have conversations is so important. – I don't think that any one person can know everything, we're just better when we talk to people and share.” — Gail W. Kosyla  Links Mentioned in Today's Episode:Gail W. Kosyla on LinkedInYale New Haven HealthLean In CirclesLean In: Women, Work, and the Will to LeadLeadership Blueprints PodcastMCFAMCFA CareersBJ Kraemer on LinkedIn

Howie and Harlan are joined by Margaret McGovern, deputy dean for clinical affairs at the Yale School of Medicine, CEO of Yale Medicine, and chief physician executive of the Yale New Haven Health System. They discuss her path from the lab to healthcare leadership, and her efforts to better align Yale's medical school and its health system. Harlan reflects on the anniversary of the September 11 attacks; Howie provides an update on the bird flu outbreak.  Links: September 11 “60 Minutes remembers 9/11: The FDNY” Margaret McGovern “McGovern Welcomed as Yale Medicine CEO” “Margaret McGovern, MD, PhD, Appointed YSM Deputy Dean and CEO of Yale Medicine” “What is Translational Research?” “Three SBU Leaders Honored for Outstanding Service During Pandemic” “What Are Relative Value Units (RVUs)?” “You're Invited: Alignment-Focused Town Halls” “Clinically Integrated Networks” “Elevating Patient Access and the Consumer Experience” Bird Flu “Current H5N1 Bird Flu Situation in Dairy Cows” “How CDC is monitoring influenza data among people to better understand the current avian influenza A (H5N1) situation” “5 burning questions about Missouri's mysterious H5 bird flu case” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Margaret McGovern, deputy dean for clinical affairs at the Yale School of Medicine, CEO of Yale Medicine, and chief physician executive of the Yale New Haven Health System. They discuss her path from the lab to healthcare leadership, and her efforts to better align Yale's medical school and its health system. Harlan reflects on the anniversary of the September 11 attacks; Howie provides an update on the bird flu outbreak.  Links: September 11 “60 Minutes remembers 9/11: The FDNY” Margaret McGovern “McGovern Welcomed as Yale Medicine CEO” “Margaret McGovern, MD, PhD, Appointed YSM Deputy Dean and CEO of Yale Medicine” “What is Translational Research?” “Three SBU Leaders Honored for Outstanding Service During Pandemic” “What Are Relative Value Units (RVUs)?” “You're Invited: Alignment-Focused Town Halls” “Clinically Integrated Networks” “Elevating Patient Access and the Consumer Experience” Bird Flu “Current H5N1 Bird Flu Situation in Dairy Cows” “How CDC is monitoring influenza data among people to better understand the current avian influenza A (H5N1) situation” “5 burning questions about Missouri's mysterious H5 bird flu case” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Lee Schwamm, associate dean for digital strategy and transformation for Yale School of Medicine and chief digital health officer for Yale New Haven Health System, to discuss how AI and other digital tools can be part of fixing a broken healthcare system. Harlan reports on lightly regulated compounding pharmacies producing anti-obesity drugs; Howie gives an update on efforts by the FDA and CDC to fight bird flu. Links: "2023 Paul Dudley White Award: Dr. Lee Schwamm" Yale School of Medicine | Lisa Leffert, MD Health & Veritas | Dr. Lisa Leffert: Leading in Anesthesiology Testimony Prepared by Dr. Lee Schwamm Submitted to the House Committee on Energy and Commerce Subcommittee on Heath "Ambient AI Is Here, And We Are Blissfully Unaware Of It" "Yale New Haven Health to provide AI-driven clinical documentation" "Abridge, Mayo Clinic, And Epic Collaborate To Develop An Integrated Artificial Intelligence Documentation Solution For Nurses" "Are You Sure Your Ozempic Is Real? Fakes Are on the Rise." "Bill on Drug Compounding Clears Congress a Year After a Meningitis Outbreak" CDC | H5 Bird Flu: Current Situation "Is Bird Flu Spreading Widely to Farm Workers? A Small Study Offers Some Reassurance" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Lee Schwamm, associate dean for digital strategy and transformation for Yale School of Medicine and chief digital health officer for Yale New Haven Health System, to discuss how AI and other digital tools can be part of fixing a broken healthcare system. Harlan reports on lightly regulated compounding pharmacies producing anti-obesity drugs; Howie gives an update on efforts by the FDA and CDC to fight bird flu. Links: "2023 Paul Dudley White Award: Dr. Lee Schwamm" Yale School of Medicine | Lisa Leffert, MD Health & Veritas | Dr. Lisa Leffert: Leading in Anesthesiology Testimony Prepared by Dr. Lee Schwamm Submitted to the House Committee on Energy and Commerce Subcommittee on Heath "Ambient AI Is Here, And We Are Blissfully Unaware Of It" "Yale New Haven Health to provide AI-driven clinical documentation" "Abridge, Mayo Clinic, And Epic Collaborate To Develop An Integrated Artificial Intelligence Documentation Solution For Nurses" "Are You Sure Your Ozempic Is Real? Fakes Are on the Rise." "Bill on Drug Compounding Clears Congress a Year After a Meningitis Outbreak" CDC | H5 Bird Flu: Current Situation "Is Bird Flu Spreading Widely to Farm Workers? A Small Study Offers Some Reassurance" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

As an Associate Professor at Yale School of Medicine, a practicing anesthesiologist and the Medical Director of Sustainability for the Yale New Haven Health System, Dr. Jodi Sherman is an internationally recognized clinician and academic in the emerging field of sustainability in healthcare. Tune in to an eye-opening conversation about healthcare pollution, ecologically sustainable practices in healthcare and the impact of health professionals for driving the sustainable transformation.

A special episode recorded at the Yale Innovation Summit, which brings together entrepreneurs and investors in the arts, biotech, climate, health, and tech. Howie and Harlan are joined by Josh Geballe, managing director of Yale Ventures, which hosts the summit; Mary Ann Melnick, site head at Biolabs New Haven; and Lee Schwamm, chief digital health officer at Yale New Haven Health System.  Links: Watch the event on YouTube. Yale Ventures: Yale Innovation Summit State of Connecticut: “Governor Lamont Announces Creation of the Innovation Clusters Program To Support Growth in Cutting-Edge Industries” Yale Ventures: Venture Lab BioLabs New Haven The Provost's Committee on Conflict of Interest “Novel BioLaunch program to train New Haven residents for careers in biotech” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

A special episode recorded at the Yale Innovation Summit, which brings together entrepreneurs and investors in the arts, biotech, climate, health, and tech. Howie and Harlan are joined by Josh Geballe, managing director of Yale Ventures, which hosts the summit; Mary Ann Melnick, site head at Biolabs New Haven; and Lee Schwamm, chief digital health officer at Yale New Haven Health System.  Links: Watch the event on YouTube. Yale Ventures: Yale Innovation Summit State of Connecticut: “Governor Lamont Announces Creation of the Innovation Clusters Program To Support Growth in Cutting-Edge Industries” Yale Ventures: Venture Lab BioLabs New Haven The Provost's Committee on Conflict of Interest “Novel BioLaunch program to train New Haven residents for careers in biotech” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Join us this week as Meena Mallipeddi welcome's guest Dr. Lee Schwamm, SVP & Chief Digital Health Officer at Yale New Haven Health System.What you'll get from this episode:Digital Health Vision: Dr. Lee Schwamm shares his journey and vision as the Chief Digital Health Officer at Yale New Haven Health.Telestroke Success: The pivotal role of telestroke in revolutionizing stroke care and its widespread adoption.Patient-Centered Care: How digital health can meet patients where they are, transforming the patient experience.Virtual Care Challenges: Addressing the administrative burden and finding innovative solutions for healthcare providers.Future of Digital Healthcare: Dr. Schwamm's outlook on transformative healthcare innovations and AI-powered care.“AmplifyMD immediately connects medical facilities to a large network of physicians in all of the most essential specialties, including Neurology, Cardiology, Infectious Disease, Pulmonology and Heme/Onc.” Their mission is access, by becoming the definitive specialty care platform that connects every medical facility to the specialty care they need to improve patient outcomes. - https://amplifymd.com/Learn more:Guest LinkedIn https://www.linkedin.com/in/doctorleeschwamm/Company LinkedIn https://www.linkedin.com/company/yale-new-haven-health-system/Company Website https://www.ynhhs.org/Follow The Seamless Connection: https://www.linkedin.com/company/the-seamless-connection

Our guests:Sara Vaezy, EVP, Chief Strategy & Digital Officer at ProvidenceLee Schwamm MD, SVP, Chief Digital Health Officer & Associate Dean, Yale New Haven Health System and Yale School of MedicineMissy Krasner, Venture Chair at Redesign HealthIn this episode, we discussed:Transforming Clinical Documentation: Discussion on ambient documentation technology and its potential to transform clinical note-taking, alleviating administrative burdens for healthcare professionals.Enhancing Patient Services Through AI: Insights into AI's role in enhancing patient-facing services, including navigation, self-service options, and empathetic communication.The Need for Responsible AI Implementation: Emphasis on the need for responsible AI implementation, considering cost, ethical governance, and the protection of patient trust and data privacy.Future Trends in Healthcare AI: Exploration of future AI applications in healthcare, such as predictive analytics and the incorporation of unstructured data like radiology and genomic information.Our sponsors for this episode are:Sage Growth Partners https://sage-growth.com/Quantum Health https://quantum-health.com/Learn more about each guest and company!Providence: https://www.providence.org/ Yale Health New Haven: https://www.ynhhs.org/Yale School of Medicine: https://medicine.yale.edu/Redesign Health: https://www.redesignhealth.com/

Audible Bleeding editor Wen (@WenKawaji) is joined by second year medical student Nishi (@Nishi_Vootukuru), 3rd year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School, JVS editor Dr. Forbes (@TL_Forbes) and JVS-CIT associate editor Dr. O'Banion (@limbsalvagedr) to discuss two great articles in the JVS family of journals regarding endovascular management of acute limb ischemia and ultrasound-based femoral artery calcification score. This episode hosts Dr. Thomas Maldonado (@TomMaldonadoMD) and Dr. Raul J. Guzman, the authors of the following papers:   Articles:   Safety and efficacy of mechanical aspiration thrombectomy at 30 days for patients with lower extremity acute limb ischemia by Dr. Maldonado and colleagues. An ultrasound-based femoral artery calcification score by Dr. Raul Guzman and colleagues.     Show Guests: Dr. Thomas Maldonado is the Schwartz - Buckley endowed professor of surgery in the Vascular Division at New York University Langone Medical Center in New York,  Co-Director of Center for Complex Aortic Disease Dr. Raul J. Guzman is the Donald Guthrie Professor of Vascular Surgery, Chief of Division of Vascular Surgery at Yale New Haven Hospital. He is also Surgeon-in-Chief of Vascular Surgery, Heart and Vascular Center for the Yale New Haven Health System. (raul.guzman@yale.edu)   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

In Episode 61 we're joined by Dr. Lee H. Schwamm, MD, and accomplished neurologist, and healthcare innovator. About our guest: Dr. Schwamm's impressive career spans over three decades, with significant contributions in academia and healthcare administration. He currently holds the role of Associate Dean for Digital Strategy and Transformation at Yale School of Medicine and serves as the Senior Vice President and Chief Digital Health Officer for Yale New Haven Health System. Dr. Schwamm is recognized as a visionary physician leader, spearheading digital health initiatives to advance virtual care and digital enablement in healthcare. Telestroke Program & Clinical Care: Dr. Schwamm shares insights into his experience implementing telestroke programs at Massachusetts General Hospital (MGH) and expanding their reach across the New England region. The conversation delves into a recent policy change in Massachusetts, where Dr. Schwamm explains how $1 million was allocated to the state Department of Public Health to enhance the transport system for suspected stroke patients. Get with the Guidelines: Dr. Schwamm discusses his leadership role in the "Get with the Guidelines" (GWTG) program and how it has evolved to enhance patient care. Digital strategy at Yale: In Part 2, the discussion shifts to Dr. Schwamm's role at Yale School of Medicine, where he leads digital strategy and transformation. He outlines the key components of his digital strategy and discusses the challenges and opportunities in adopting digital healthcare solutions. Dr. Schwamm shares his insights into the barriers to digital adoption in the healthcare industry and offers his perspective as an influential change agent. Promising Technologies and the Magic Wand: The episode concludes with a look into the most promising technologies that could revolutionize clinical care and outcomes for stroke patients. Dr. Schwamm responds to the signature question, imagining a scenario where he's handed a magic wand and asked to redesign the stroke care pathway. Show Credits: Music intro credit to Jake Dansereau. Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast. Be sure to give the show a like and share, & follow and connect with us on social or contact us to support us as a show sponsor or become a guest on the Know Stroke Podcast. Visit website to to learn more: https://www.knowstrokepod.com/ Connect with Us and Share our Show on Social: Website | Linkedin | Twitter | YouTube | Facebook

September 14: Today on TownHall we are taking another look back at an episode from last fall. In this episode Sue Schade, Principal at StarBridge Advisors talked with Lisa Stump, SVP, Chief Information & Digital Transformation Officer at Yale New Haven Health System. What are some of her team's current initiatives and how have things changed since the height of the pandemic? What are some of the challenges in dealing with two different constituencies in the university environment and the health system environment? What are some of her key takeaways and successes regarding her involvement with an important leadership development program?Join us for our webinar "Interoperability Outcomes: A Discussion of What's Possible" on October 5th at 1 PM ET/10 AM PT, discussing challenges in healthcare interoperability. We'll tackle key issues like fragmented technology systems, data privacy, and cost-effectiveness. Engage with top-tier experts to understand the current landscape of healthcare IT, learn data-driven strategies for patient-centered care, and discover best practices for ensuring system security and stakeholder trust. Register Here - https://thisweekhealth.com/interoperability-outcomes/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Welcome to the Becker's Healthcare podcast, where Molly Gamble engages in a captivating conversation with Christopher O'Connor, President and CEO of Yale New Haven Health System. With an impressive background and deep experience within the organization, Christopher shares insights and lessons learned from his tenure as COO under the leadership of Marna Borgstrom, whom he succeeded as CEO. They delve into the dynamics of a healthy CEO-COO relationship and discuss the milestones that have shaped Christopher's first year in his current role. The conversation also explores the financial challenges faced by hospitals and health systems in 2022 and the anticipated impact over the next few years. Christopher sheds light on the pressing issues demanding his attention at Yale New Haven Health and highlights his concerns and priorities for the future. Join us for this engaging episode filled with valuable insights from a seasoned healthcare leader.

{This program originally aired live on Sunday May 21, 2023.} Since April 15, there has been violent conflict between Sudan's military, and a rival paramilitary faction known as the Rapid Support Forces, or RSF. Reports from the country have the current death toll at 850 people. Joining host Mike Merli to speak about this urgent humanitarian crisis is Dr. Fawatih Mohamed Abouh, Assistant Professor at UConn Health, Epidemiologist with Yale New Haven Health System, and member of Connecticut's large and vibrant Sudanese-American community. Organizations engaged in direct response work include: Sudanese American Physicians Association (SAPA) https://sapa-usa.org/sudan-war-crisis-emergency-relief/ https://www.facebook.com/SAPAinUS/ Sudanese American Womens Doctors Association (SAWDA) https://www.sawda-us.org/ Community Medical Response Team (CMRT) is a team engaged in crisis intervention work on the ground in Sudan. It was created amid the COVID-19 Pandemic and continues to provide critical services to people in need. It is a branch of the American non-profit Sustainable Development Response Organization (SUDRO). https://sudro.org/ For important background on the humanitarian crisis unfolding in Sudan: https://www.aljazeera.com/news/2023/5/16/women-speak-out-online-about-reports-of-sexual-violence-in-sudan https://www.theguardian.com/global-development/2023/may/16/sudan-reports-of-women-being-raped-in-khartoum-by-armed-men https://www.middleeastmonitor.com/20230517-sudan-increased-instances-of-rape-lead-doctor-to-post-details-of-measures-to-take/ https://www.nytimes.com/topic/destination/sudan

The path to managing a billion-dollar university endowment is not always the same, and in the case of Geeta Kapadia, there were twists and turns along the way. As the CIO at Fordham University, Geeta is a key member of the University's executive leadership team, collaborating with the Board of Trustees Finance and Investment Committee and senior leaders in finance, to develop and execute the University's investment strategy. Prior to joining Fordham in August of 2022, Geeta was the associate treasurer for investments with the nonprofit Yale New Haven Health System, the largest health care system in Connecticut, responsible for over $5 billion in assets. Before her long tenure at Yale, Geeta was a senior investment consultant at Mercer, and investment analyst at Capital Metrics. She is a CFA Charterholder, and longtime member of the CFA Institute, having served on its disciplinary review committee, graded exams, and mentored several investment professionals throughout their pursuit of the CFA Charter. On today's podcast, Geeta talks about her unique path to our industry and leadership roles, guidance for young professionals, and inspiration we can all use during difficult and uncertain times.

Dr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there.   Dr. Tro has also published research on the topics of Achalasia, Binge Eating Disorder, Food Addiction, and Severe Hypertriglyceridemia. He has worked on several clinical research projects, including a study that demonstrated the statistically significant impact of a novel hospital-based safety initiative, a systemic review comparing treatment options for neuropathic pain, a clinical trial that established a relationship between post-exercise ABI and a positive nuclear stress test.   Dr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome, and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management, and mental health.   Dr. Tro has extensive training in point-of-care ultrasound. He has achieved board certification in both Obesity Medicine and Internal Medicine.   In this Episode: Tro's personal story: Addiction, Eating Disorders, Obesity Separating dogma from personal needs and recovery His program, results, effectiveness Addiction screening GLP Medications Low Carb MD podcast The future of bariatric medicine Signature Question   Follow Dr. Tro: Website: https://doctortro.com/ Facebook:  https://www.facebook.com/DoctorTro/ Instagram: https://www.instagram.com/doctortro/ Youtube: https://www.youtube.com/c/DrTroKalayjian ANNOUNCEMENT: You Are Not What You Weigh: Getting over the Scale LIVE Workshop brought to you by Bethany Mazereeuw. Bethany uses her Master of Social Work to coach you through to a recovery plan that works for you. She offers high challenge, accountability, authenticity, and lots of grace on this road to recovery. This workshop is for you if: ·        you suspect you might be giving too much 'weight' to your weight; ·        if you have ever allowed the scale to have power over your mood, day, actions, confidence; ·        if you are tired of giving too much thought or priority to your weight; ·        or if you just want to know more about the BMI, weight and health, weight stigma, weight bias, and what weight loss does to us physically and mentally. Over 4 pre-recorded video sessions, Bethany dives deep into the research and her own personal story making this a very practical exploration of the concept of body weight as a measure. The homework after each video is designed to help you get the most out of this workshop. Bethany has also provided a list of resources (books, podcasts, Instagram accounts, meditations, etc.) to help you explore concepts from the workshop even further. You can also join in weekly live group sessions to share what you're learning and ask questions on: Wednesday, April 05 @2pm EDT / 7pm UK Wednesday, April 12 @2pm EDT / 7pm UK Wednesday, April 19 @2pm EDT / 7pm UK Wednesday, April 26 @2pm EDT / 7pm UK Sessions will be recorded, and a replay will be made available to you. REGISTER HERE: https://www.sweetsobriety.ca/courses/you-are-not-what-you-weigh-live-workshop   The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.  

Today's episode is sponsored by Paleovalley's Pasture-Raised Pork Sticks.  My favorite meat stick so far. Make sure to support this podcast and head over to Paleovalley.com/NwJ and use code NWJ to get 15% off your first order._____I'm excited to sit down with Dr. Tro Kalayjian. We talk about food addiction, obesity and much more. Make sure to listen to the full interview to learn more.Dr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there.Dr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management, and mental health. Dr Tro is co-host of the popular LowCarbMD podcast. We discuss the following:All about Dr. TroDr. Tro's telemedicine insurancePlant-based diet experienceFood addictionHow to educate people with the right dietNutrition and. behaviorObesity and diabetesCarnivore as a toolSupplementsCholesterol on a carnivore dietOther levers for healingHow to afford keto foods and meatsTips for healing and better healthWhere to find Dr. Tro_____RESOURCESWebsite: https://doctortro.com/ Facebook: https://www.facebook.com/DoctorTro/ Instagram: https://www.instagram.com/doctortro/ Twitter: https://twitter.com/DoctorTro YouTube: https://www.youtube.com/c/DrTroKalayjian Dr. Tro App: https://doctortro.com/community/ Low Carb MD Podcast: https://www.lowcarbmd.com/ ____CHECK OUT MY BOOK, Carnivore CureSIGN UP FOR MY WEEKLY NEWSLETTER_____ ADDITIONAL RESOURCESNutrition with Judy ArticlesNutrition with Judy ResourcesCutting Against the Grain Podcast_____ FIND ME

Meet James Staten:James Staten is the Senior Vice President of Finance and Chief Financial Officer for the University of Southern California (USC). In addition, he serves on the Board of Directors for the Keck Medicine of USC and USC's three captive insurance companies. Prior to USC, James serves as Executive Vice President and Chief Financial Officer for Yale New Haven Health System. James received a bachelor's degree in business and economics from the State University College of New York.  Key Insights:USC will be leaving the Pac-12 conference to join the Big 10. In this focused conversation, James Staten explains the factors behind the decision. Background Factors. Like many big college athletic programs, USC had run into deficits over the last few years, which negatively impacts facilities and recruitment. Additionally, this decision came at a time when the conference was about to soon enter media rights negotiations. Why the Big 10? USC decided to join the Big 10 because the increased media exposure would benefit student athletes as well as the university's national exposure and revenue. Additionally, it is a better academic conference.Healthcare vs Higher Ed. Higher education is favoring more partnerships and affiliations, rather than the consolidations seen in the healthcare sector. Relevant Links: Learn more about James StatenRead “Not your conventional chief financial officer”

In this week's episode of Clean Talk, Thomas Balcezak, Chief Clinical Officer at Yale New Haven Health System, joins us to reveal his mission to expand and improve care for communities.Tune in to hear about a range of topics including:• Thomas Balcezak's professional background and how he got to where he is today• About Yale New Haven Health System• How Yale New Haven Health will continue to expand their programs and improve care for communities.• Challenges brought on by COVID-19• How the pandemic really showed the strength of the system.• Yale New Haven Health clinical care protocols, standards, etc.• The importance of operating everything as a system and not as individual hospitals• Biweekly town hall meetings for all employees in order to stay up to date during the pandemic• Predictions For The FutureDr. Thomas Balcezak, MD is Chief Clinical Officer at Yale New Haven Health System and has over 30 years of experience in the medical field. He graduated from University of Connecticut in 1992.Clean Talk Registration: https://cleantalk.onlineClean Talk Official Website: https://cleantalk.tvClean Talk YouTube: https://youtube.com/CleanTalk_TVLinkedin Group: https://linkedin.com/groups/9094477/Facebook Group: https://facebook.com/groups/986587845276744

August 23: Today on TownHall, https://www.linkedin.com/in/sue-schade-4a12887/ (Sue Schade), Principal at https://www.starbridgeadvisors.com (StarBridge Advisors) speaks with https://www.linkedin.com/in/lisa-stump-877b5213/ (Lisa Stump), SVP, Chief Information & Digital Transformation Officer at https://www.ynhhs.org/ (Yale New Haven Health System). What are some of her team's current initiatives and how have things changed since the height of the pandemic? What are some of the challenges in dealing with two different constituencies in the university environment and the health system environment? What are some of her key takeaways and successes regarding her involvement with an important leadership development program? Sign up for our webinar: https://thisweekhealth.com/briefing_campaigns/challenges-and-solutions-to-unmanaged-devices-in-healthcare/ (Challenges and Solutions to Unmanaged Devices in Healthcare) - Thursday September 8, 2022: 1pm ET / 10am PT

Today's episode features two successful senior level executive women in healthcare. We have Gayle Capozzalo, MSPH, Executive Director of The Equity Collaborative, which is part of the Carol Emmott Foundation - a national nonprofit dedicated to achieving fully inclusive gender equity in healthcare leadership and governance and retired Executive Vice President/Chief Strategy Officer of Yale New Haven Health System. Also joining us is Morgan Jones, MSPH, Vice President of Strategic Planning and Business Development for Duke Health and Board Member of the Carol Emmott Foundation. Morgan was previously interim assistant director (Assistant Chief Operating Officer) and strategic planner at the Durham VA Medical Center.  Gayle and Morgan will discuss how to position yourself as a woman in the industry – how to acquire the necessary skills to be a successful leader and offer personal insight as senior level executives in the field.

Harlan explains what the research says about the immunity acquired from a COVID-19 infection, and suggests a framework for thinking about exposure risk. Then Howie and Harlan are joined by Thomas Balcezak, chief clinical officer at the Yale New Haven Health System. They discuss the financial and human capital challenges faced by hospitals in the wake of the pandemic. Links: “Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2” “Medical Education in the United States and Canada” (The Flexner Report) About Yale New Haven Health “Mass General Brigham says it will reduce spending by $70m annually” “US Mass Shootings, 1982–2022: Data From Mother Jones' Investigation”

Harlan explains what the research says about the immunity acquired from a COVID-19 infection, and suggests a framework for thinking about exposure risk. Then Howie and Harlan are joined by Thomas Balcezak, chief clinical officer at the Yale New Haven Health System. They discuss the financial and human capital challenges faced by hospitals in the wake of the pandemic. Links: “Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2” “Medical Education in the United States and Canada” (The Flexner Report) About Yale New Haven Health “Mass General Brigham says it will reduce spending by $70m annually” “US Mass Shootings, 1982–2022: Data From Mother Jones' Investigation”

A national nursing shortage has deepened during the pandemic. A recent survey by the American Association of Critical-Care Nurses found that 92% of nurses felt that the pandemic had "depleted nurses in their hospital, and that their career would be shorter than they had intended as a result." This hour, we hear about a new plan to address part of the pipeline problem. Yale New Haven Health System is partnering with four area nursing schools to expand enrollment and, hopefully, the local workforce. Plus, lawmakers want to look into the agencies recruiting travel nurses, sparking fears of capped pay. We hear more about the context for a “travel nursing boom" from author Sarah DiGregorio and Paul Banach, an ICU travel nurse from Connecticut. DiGregorio underscores working conditions and a longer-term "undervaluing" of nurses. She says "the problematic explosion of traveling nursing is only a symptom of a longer-running, self-inflicted disaster: Over the long-term, hospitals have failed to hire and support enough nurses to weather crises." GUESTS: Beth Beckman: Chief Nursing Executive, Yale New Haven Health System Paul Banach: Intensive Care Travel Nurse, MPH, BSN, RN Sarah DiGregorio: Author, Early: An Intimate History of Premature Birth and What It Teaches Us About Being Human Support the show: http://wnpr.org/donate See omnystudio.com/listener for privacy information.

Today I have the President and CEO of WILL Interactive, Inc., Sharon Sloane. Aside from the incredible story behind the success and the walk down memory lane, this episode also provides a TON of golden nuggets of wisdom. If you are a leader in whatever shape or form, you are definitely going to learn a lot from today's interview with Sharon Sloane. Make sure you tune in.Sharon Sloane has 30 years of experience designing leading-edge instructional systems for behavior modification and performance improvement. She holds a U.S. Patent for creating computer-based interactive movie software to help improve human performance. Her work has been featured on NBC, CNN, NPR, as well as in Forbes magazine, Time magazine, the Washington Post, Washington Times, and approximately 50 other newspapers. Her work has received over 80 awards, including the Woman of Vision award given by Women in Film and Video, New York Festivals "World Medals," a Platinum dotcom award, and Software Information Industry Association's "Codie."As one of the leading innovators in the learning and communication industry, Sharon has worked with many of America's most prestigious organizations and touched some 30 million users. WILL partners include AIG, Yale New Haven Health System, U.S. Department of Health and Human Services, all branches of the U.S. Military; the National Football League, FBI, law enforcement agencies in the US, UK, Canada, Australia, Japan, and Israel, as well as hospitals, financial institutions, and schools across the country.Sharon has been a keynote speaker at multiple conferences, including Revolutionary Learning, the American Medical Association's annual meeting, National Reconnaissance Office's Annual Conference on Visual Media, HR Healthcare's 2021 Conference, and Serious Games Summit. Her expertise has been referenced in several books, including Scenario-based eLearning: Evidence-based Guidelines for Workforce Training, Digital Game Based Learning, Learning by Doing, and Simulation and the Future of Learning.Reach out:Web: https://willinteractive.com/Email: sharon@willinteractive.comSharon's Linkedin: https://www.linkedin.com/in/sloanesharon/WILL Linkedin: https://www.linkedin.com/company/will-interactive/Show notes:[3:03] How'd it happen for Sharon Sloane[6:37] Did Sharon choose the path of becoming a CEO of a software company?[8:37] What she thought she'd want to become growing up[13:17] The golden nuggets Sharon learned from her father and the development of training[20:36] On dealing with people who don't think training is necessary[25:57] Diving deeper into e-learning[31:02] How Sharon marketed herself and her “crazy” idea[37:37] The process of putting the training together[41:23] As a learning and assessment tool[46:34] How Sharon has grown and developed as a leader and on persistently improving herself[49:29] Let's talk about the platinum rule vs. golden rule, beam holder, chair time[55:39] Sharon's quiet time[57:45] A difficult situation Sharon's company went through[1:01:45] Where to connect with SharonCheck the accompanying blog post of this episode at: https://mikemalatesta.com/podcast/sharon-sloane-how-i-learned-to-sell-a-rainbow-226/If you like this episode and want to be the first to know when new ones are released? Make sure you subscribe! Also, a review will be much appreciated, so make sure you give us a 5-star (or whatever one makes the most sense to you). Connect with Mike:Website: https://mikemalatesta.com/LinkedIn: https://www.linkedin.com/in/mikemalatesta/

Today I have the President and CEO of WILL Interactive, Inc., Sharon Sloane. Aside from the incredible story behind the success and the walk down memory lane, this episode also provides a TON of golden nuggets of wisdom. If you are a leader in whatever shape or form, you are definitely going to learn a lot from today's interview with Sharon Sloane. Make sure you tune in.Sharon Sloane has 30 years of experience designing leading-edge instructional systems for behavior modification and performance improvement. She holds a U.S. Patent for creating computer-based interactive movie software to help improve human performance. Her work has been featured on NBC, CNN, NPR, as well as in Forbes magazine, Time magazine, the Washington Post, Washington Times, and approximately 50 other newspapers. Her work has received over 80 awards, including the Woman of Vision award given by Women in Film and Video, New York Festivals "World Medals," a Platinum dotcom award, and Software Information Industry Association's "Codie."As one of the leading innovators in the learning and communication industry, Sharon has worked with many of America's most prestigious organizations and touched some 30 million users. WILL partners include AIG, Yale New Haven Health System, U.S. Department of Health and Human Services, all branches of the U.S. Military; the National Football League, FBI, law enforcement agencies in the US, UK, Canada, Australia, Japan, and Israel, as well as hospitals, financial institutions, and schools across the country.Sharon has been a keynote speaker at multiple conferences, including Revolutionary Learning, the American Medical Association's annual meeting, National Reconnaissance Office's Annual Conference on Visual Media, HR Healthcare's 2021 Conference, and Serious Games Summit. Her expertise has been referenced in several books, including Scenario-based eLearning: Evidence-based Guidelines for Workforce Training, Digital Game Based Learning, Learning by Doing, and Simulation and the Future of Learning.Reach out:Web: https://willinteractive.com/Email: sharon@willinteractive.comSharon's Linkedin: https://www.linkedin.com/in/sloanesharon/WILL Linkedin: https://www.linkedin.com/company/will-interactive/Show notes:[3:03] How'd it happen for Sharon Sloane[6:37] Did Sharon choose the path of becoming a CEO of a software company?[8:37] What she thought she'd want to become growing up[13:17] The golden nuggets Sharon learned from her father and the development of training[20:36] On dealing with people who don't think training is necessary[25:57] Diving deeper into e-learning[31:02] How Sharon marketed herself and her “crazy” idea[37:37] The process of putting the training together[41:23] As a learning and assessment tool[46:34] How Sharon has grown and developed as a leader and on persistently improving herself[49:29] Let's talk about the platinum rule vs. golden rule, beam holder, chair time[55:39] Sharon's quiet time[57:45] A difficult situation Sharon's company went through[1:01:45] Where to connect with SharonCheck the accompanying blog post of this episode at: https://mikemalatesta.com/podcast/sharon-sloane-how-i-learned-to-sell-a-rainbow-226/If you like this episode and want to be the first to know when new ones are released? Make sure you subscribe! Also, a review will be much appreciated, so make sure you give us a 5-star (or whatever one makes the most sense to you). Connect with Mike:Website: https://mikemalatesta.com/LinkedIn: https://www.linkedin.com/in/mikemalatesta/

QUESTION PRESENTED:(1) Whether deference under Chevron U.S.A. v. Natural Resources Defense Council permits the Department of Health and Human Services to set reimbursement rates based on acquisition cost and vary such rates by hospital group if it has not collected adequate hospital acquisition cost survey data; and (2) whether petitioners' suit challenging HHS's adjustments is precluded by 42 U.S.C. § 1395l(t)(12).Date                  Proceedings and Orders (key to color coding)Feb 10 2021 | Petition for a writ of certiorari filed. (Response due March 15, 2021)Feb 23 2021 | Brief amici curiae of 36 State and Regional Hospital Associations filed.Mar 03 2021 | Motion to extend the time to file a response from March 15, 2021 to April 14, 2021, submitted to The Clerk.Mar 04 2021 | Motion to extend the time to file a response is granted and the time is extended to and including April 14, 2021.Mar 12 2021 | Brief amici curiae of Yale New Haven Health System, BJC Health Care, UPMC and Vanderbilt University Medical Center filed.Mar 31 2021 | Brief amicus curiae of Federation of American Hospitals filed.Apr 08 2021 | Motion to extend the time to file a response from April 14, 2021 to May 13, 2021, submitted to The Clerk.Apr 09 2021 | Motion to extend the time to file a response is granted and the time is further extended to and including May 13, 2021.Apr 13 2021 | Brief amicus curiae of Rural Hospital Coalition in support of respondent filed.May 13 2021 | Brief of respondent Xavier Becerra, Sec. of H&HS in opposition filed.May 28 2021 | Reply of petitioners American Hospital Association, et al. filed. (Distributed)Jun 01 2021 | DISTRIBUTED for Conference of 6/17/2021.Jun 21 2021 | DISTRIBUTED for Conference of 6/24/2021.Jul 01 2021 | DISTRIBUTED for Conference of 7/1/2021.Jul 02 2021 | Petition GRANTED. In addition to the question presented by the petition, the parties are directed to brief and argue the following question: Whether petitioners' suit challenging HHS's adjustments is precluded by 42 U. S. C. §1395l(t)(12).Jul 09 2021 | Blanket Consent filed by Petitioner, American Hospital Association, et al.Jul 26 2021 | Motion for an extension of time to file the briefs on the merits filed.Jul 28 2021 | Motion to extend the time to file the briefs on the merits granted. The time to file the joint appendix and petitioners' brief on the merits is extended to and including September 3, 2021. The time to file respondents' brief on the merits is extended to and including October 20, 2021.Sep 03 2021 | Brief of petitioners American Hospital Association, et al. filed.Sep 03 2021 | Joint appendix filed. (Statement of costs filed)Sep 08 2021 | Brief amicus curiae of Pacific Legal Foundation filed.Sep 09 2021 | Brief amici curiae of 37 State and Regional Hospital Associations filed.Sep 10 2021 | Brief amicus curiae of Americans for Prosperity Foundation in support of neither party filed.Sep 10 2021 | Brief amici curiae of National Association of Home Builders, et al. filed.Sep 10 2021 | Brief amicus curiae of Chamber of Commerce of the United States of America in support of neither party filed.Sep 10 2021 | Brief amici curiae of Yale New Haven Health System, et al. filed.Sep 10 2021 | Brief amicus curiae of National Right to Work Legal Defense Foundation, Inc. filed.Sep 10 2021 | Brief amicus curiae of New Civil Liberties Alliance filed.Sep 10 2021 | Brief amici curiae of States of Indiana, et al. filed.Sep 20 2021 | SET FOR ARGUMENT on Tuesday, November 30, 2021.Sep 27 2021 | Record requested from the U.S.C.A. D.C. Circuit.Oct 01 2021 | The record received from the U.S.C.A. DC Circuit is electronic and located on Pacer, also received are transcripts that has been electronically filed.Oct 20 2021 | Brief of respondents Xavier Becerra, Sec. of H&HS, et al. filed.Oct 27 2021 | Brief amicus curiae of Rural Hospital Coalition filed. (Distributed)Oct 27 2021 | Brief amicus curiae of Federation of American Hospitals filed. (Distributed)Oct 29 2021 | CIRCULATEDNov 19 2021 | Reply of petitioners American Hospital Association, et al. filed. (Distributed)Nov 30 2021 | Argued. For petitioners: Donald B. Verrilli, Jr., Washington, D. C. For respondents: Christopher G. Michel, Assistant to the Solicitor General, Department of Justice, Washington, D. C.★ Support this podcast on Patreon ★

In Episode 129 of The Win-Win Effect™ Show, @lordchrisross  has an earth-shattering conversation with an extremely powerful woman that has been busy setting and raising the bar for the last 30 years, SHARON SLOANE.  ➥ https://willinteractive.com Sharon Sloane is the President and CEO of WILL Interactive, Inc., With over 30 years of experience designing leading-edge instructional systems for behavior modification and performance improvement. She holds a U.S. Patent for creating computer-based interactive movie software to help improve human performance. Her work has been featured on NBC, CNN, NPR, and in Forbes magazine, Time magazine, the Washington Post, Washington Times, and approximately 50 other newspapers. Her work has received over 80 awards, including the Woman of Vision award was given by Women in Film and Video, New York Festivals "World Medals," Platinum dotcom award, and Software Information Industry Association's "Codie." As one of the leading innovators in the learning and communication industry, Sharon has worked with many of America's most prestigious organizations and touched 30 million users. WILL partners include AIG, Yale-New Haven Health System, U.S. Department of Health and Human Services, all branches of the U.S. Military; the National Football League, FBI, law enforcement agencies in the U.S., UK, Canada, Australia, Japan, and Israel, as well as hospitals, financial institutions, and schools across the country. Sharon has been a keynote speaker at multiple conferences, including Revolutionary Learning, the American Medical Association's annual meeting, National Reconnaissance Office's Annual Conference on Visual Media, H.R. Healthcare's 2021 Conference, and Serious Games Summit. In addition, her expertise is referenced in several books, including Scenario-based eLearning: Evidence-based Guidelines for Workforce Training, Digital Game-Based Learning, Learning by Doing, and Simulation and the Future of Learning. Sharon holds an M.A. in Counseling from the University of Connecticut and a B.S. in Education from Boston University. Connect with and JOIN FREE COMMUNITY  Community Content About CHRIS ROSS® Booking The WIN-WIN Effect WINJECT TV Already have an account? Log In First Name * Last Name * Password * Confirm Password *

The Evolution of Long-Term Asset Allocation with Al Kim, Director of Investments, Helmsley Charitable Trust. Geeta Kapadia, Associate Treasurer of Investments, Yale New Haven Health System. Angelique Sellers, Managing Director of Investments, Pennsylvania State University Office of Investment Management.Moderated by Bill Kelly, Chief Executive Officer, CAIA Association.—————————————————————— Watch this video on YouTube: https://www.youtube.com/c/SALTTube/videosFor podcast transcripts and show notes, visit https://salt.org/salt-ny-librarySALT New York is a global thought leadership and networking forum at the intersection of finance, technology and public policy. Over the course of three days, leading investors, creators and thinkers will take the stage in support of SALT's mission: empowering big ideas. #SALTNY

In this episode, I talk with Dr. Jay Morris about servant leadership and a whole lot more: his fascinating career, and his role running the education function at Yale New Haven Health System. Learn more about Yale New Haven Health at their website: https://www.ynhhs.org/

During this episode, Richard Goldstein, MD, MHCM, SentryHealth co-founder, Chief Medical Officer for Northeast Medical Group and VP of Yale New Haven Health System, talks about the importance of having a chronic disease management program in the workplace. He discusses how these types of programs can help employers control costs and how COVID-19 has changed how we view the management of chronic conditions.

In this episode of Fireside Chat, we sit down with Marna Borgstrom, President, and CEO, Yale New Haven Health System, to discuss the growth of regional health networks, the threat to academic medical centers posed by the payment system, telemedicine, the likelihood of M&A caused by the coronavirus pandemic, and the role that health systems are playing to support the public health infrastructure.

Evie Marcolini, MD is an Assistant Professor of Emergency Medicine and Neurocritical Care.  She has clinical appointments in the Department of Emergency Medicine and the Department of Neurology; and is core faculty in the Emergency Department as well as the Division of Neurocritical Care and Emergency Neurology at Yale. She has board certifications in Emergency Medicine and Neurocritical Care, and is fellowship-trained in Surgical Critical Care from the R Adams Cowley Shock Trauma Center in Baltimore, Maryland.   Evie is Medical Director for the SkyHealth Critical Care helicopter transport service that is shared between Yale-New Haven Health System and Northwell Health. She is a Fellow of the American College of Critical Care Medicine, American Academy of Emergency Medicine (AAEM) and American College of Emergency Physicians (ACEP), and is a member of the Board of Directors for AAEM. She is the past Chair of the Critical Care Section of ACEP, and active in all three societies, with a goal of bringing emergency physicians to the forefront of critical care in all realms. Evie is an active educator and speaker, with an interest in neurocritical care topics as they relate to emergency medicine and bioethics as it relates to emergency medicine and critical care patients. She has, and continues to lecture nationally and internationally, and has won the ACEP Junior Faculty Teaching Award. Evie is very active in bioethics, as a member of the Yale-New Haven Health Ethics Committee and the Society for Critical Care Medicine (SCCM) Ethics committee, and teaches ethics seminars in the ethics of neuroscience and of emergency medicine annually for the Sherwin B. Nuland Summer Institute in Bioethics at Yale. She has been awarded the Grenvik Family Ethics Award from SCCM. Evie is a co-editor of the textbook: Emergency Department Resuscitation of the Critically Ill, which is now in its second edition, is a co-author of an upcoming book on mechanical ventilation in emergency medicine. She has been active as faculty for Wilderness Medical Associates International since 1992, and teaches wilderness medical courses to medical students, residents, faculty and allied health professionals nationally and internationally, as well as having served as Faculty Advisor to wilderness medicine interest groups at the University of Maryland and Yale. When not involved in academic pursuits, Evie loves to spend her time running and skijoring with her two Siberian Huskies. Please leave us your thoughts and comments, we'd love to dig further into this topic.  Make sure to leave @EMS_Nation a 5 star review wherever you listen to podcasts and to share the episode with friends and colleagues to pass along this #FOAMed resource. Checkout the blog at EMSNation.org and say hello to Dr. Faizan H. Arshad on Twitter and Instagram @emscritcare. Wishing everyone a safe tour!

Few aspects of modern life have been unscathed by the COVID-19 pandemic and the corners of the human mind are no exception. In this episode, Dr. Minni Malhorta talks about the power of connection and relationship during a pandemic. We start off by taking a detailed look at the latest research to come out of Yale University and Yale New Haven Health System, which shines a light on the dangerous relationship between poor mental health and COVID-19. You’ll hear about how psychiatric disorders like depression and anxiety are inflammatory conditions, and how their associated medications could increase your risk of coronavirus complications and death. This is where human connection comes in. Minni explains the importance of supporting those with psychiatric comorbidities, especially during times of pandemic, and goes on to share a thorough list of how you can help those around you. Reach out to old friends and family, organize a Skype movie night, and even take part in virtual fitness competitions. For more suggestions and valuable insight, be sure to tune in today!Key Points From This Episode:Introducing today’s topic of connecting through relationships during a pandemic.How stress can impact your health and life expectancy. Hear about psychiatric comorbidities and their relationship to COVID-19.Why people with anxiety, depression, or both, need support.The physical nature of psychiatry disorders.The link between psychiatric medications and your body’s response to COVID-19.How you can alleviate stress by staying connected with family.Depression and anxiety make us want to disconnect.The important balance you need to keep when using technology and social media. Minni’s 10 ways you can connect with family, friends, and associates.How exercise machines combined with technology are a great way to connect with others.Why it’s vital that you check up on the mental health of those around you. How this episode is related to Minni’s COPE methodology.Links Mentioned in Today’s Episode:Anchor Wellness CenterPubMedYale UniversityYale New Haven Health SystemThe Lancet PsychiatrySkype

In this episode of Fireside Chat, we sit down with James Staten, Senior Vice President and CFO at the University of Southern California to talk about the leadership lessons gained throughout his professional career in public accounting and his experience in the formation of NewYork-Presbyterian to the expansion of the Yale-New Haven Health System. We also discussed other learnings from his career in healthcare and how that has served him in his role in academia.

I'm so fortunate to have Dr. Tro Kalayjian on the show today. Dr. Tro was able to lose 150 lbs and find his health again after a lifetime of obesity and struggle with his weight. He has dedicated his life to helping people lose weight and get healthy again and is on a mission to help others understand how to reach their goals and understand their hunger signals.  Dr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there. He has been involved in multiple research projects and Dr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management and mental health. I'm so excited to have him on today and If you need more information please check him out at www.drtro.com and in instagram @doctortro He also has a really great Podcast If you want to learn more its called The Low Carb MD Podcast. Here is a link   https://podcasts.apple.com/us/podcast/low-carb-md-podcast/id1441557261  As always I welcome feedback from YOU! I love to know if I am bring valuable information and guests to the show and I want to answer those burning questions that have been weighing on your mind.  Shoot me a message on my website www.connienightingale.com or shoot me a DM in Instagram @conniebegonnie  --- Support this podcast: https://anchor.fm/thefitfarmingfoodmom/support

In this health care podcast, I am talking with Yauheni Solad, MD. Dr. Solad is one of the top minds in data and data exchange. He’s medical director of digital health and telemedicine at Yale New Haven Health, and he has a mission to lead digital transformation toward accessible and affordable high-quality care that’s enabled by technology. Dr. Solad also does a lot of work with NODE—the Network of Digital Evidence. In the conversation we’re about to have, Dr. Solad represents the provider point of view. The show also features the one and only Rahul Dubey, hero to peaceable protesters. You can search for Rahul Dubey protesters to see what I mean. And also, he is the founder of Percynal Health Innovations. Rahul is the former chief innovation officer over at AHIP—that is, America’s Health Insurance Plans. In this conversation, Rahul represents the payer point of view. Here’s what we’re talking about, and I’m gonna keep this brief: It has been postulated that technology will be a catalyst for health care transformation. By technology, I mean the leaps many systems of care have made in their technological capabilities to deal with the realities of C-19. Dr. Solad, Rahul Dubey, and I talk about whether and how greater digital capability—which often means greater ability to care for populations vis-à-vis remote monitoring and telehealth—but whether, you know, the tail can wag the dog, so to speak, because so much investment has been made in these technology capes that we’re gonna want to use them. And when we use them, we transform care delivery. You can learn more by connecting with Dr. Solad on Twitter at @ysolad or on LinkedIn. You can also connect with Rahul via email or LinkedIn. Yauheni Solad, MD, MHS, is the medical director of digital health and telemedicine at Yale New Haven Health System. He is a practicing physician, clinical informaticist, and entrepreneur with a strong hands-on experience in software and data standards development with a particular focus on enabling the next wave of value-based care innovation. Yauheni received his medical degree summa cum laude from Belarusian State Medical University and a Master of Health Science from Yale School of Public Health. He is currently completing his executive MBA at Yale School of Management. Rahul Dubey is CEO of Percynal Health Innovations and the founder of America’s Health Insurance Plans (AHIP) Innovation Lab. Rahul is currently responsible for collaborating with C-level executives at his health plan. Prior to joining AHIP and launching Percynal Health Innovations, Rahul held a leadership role as a founding employee of a successful digital health care start-up based in Washington, DC. Along with the company’s cofounders, Rahul was instrumental in developing a multifaceted consumer tool as well as leading the company’s “go-to-market strategy,” resulting in successful market penetration and revenue growth for the industry’s first consumer-led shared decision making and treatment selection platform. Rahul was recognized with the Smart Health’s 2018 Excellence in Healthcare Transformation award, was named the American Journal of Health Promotion’s 2017 Innovators and Game Changers, and is featured in Accenture Perspectives: Minds Driving the Future of Business. In 2017, Frost & Sullivan presented Rahul with one of their highest honors, their Global Visionary Innovation Leadership Award. He is a graduate of the University of Michigan–Ross School of Business and lives in Washington, DC, with his son. He invites you to contact him directly—that is, if you’re willing to roll up your sleeves and drive transformation through inflective collaborative. 03:56 How COVID-19 affects interoperability. 07:06 “It’s not only the data exchange; it’s your ability as a health care system to innovate.”—Dr. Solad 09:11 How close are we to adopting more innovative and better technologies? 11:32 “Make docs happy. That is a very foreign concept for … people that are not delivering care to think about.”—Rahul 11:47 “We want to be able to enable the primary care physician to deliver care.”—Rahul 12:03 Working doctors rather than “dictating upon them.” 13:16 “I can’t sell burnout … I can sell value of care and outcomes of less cost.”—Rahul 18:44 “There might be an increase in overconsumption of care.”—Rahul 19:14 The possible increase in utilization of care and the potential for lower cost sharing. 19:57 Unlimited primary care and the benefits this might offer. 22:59 Does this pose risks to health systems? 25:22 “Everything you do for the patient should have a clear value to them.”—Dr. Solad 26:35 “What type of technology can provide this missing link for your particular health care system?”—Dr. Solad 28:18 Reimbursement as the new HIPAA. 29:15 “We need more evidence in data around the delivery of this technology-enabled service.”—Dr. Solad 32:20 What payers and providers should be doing today. 35:16 Care management vs consumerism. You can learn more by connecting with Dr. Solad on Twitter at @ysolad or on LinkedIn. You can also connect with Rahul via email or LinkedIn. Check out our newest #healthcarepodcast with @ysolad and Rahul Dubey as they discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #podcast #digitalhealth #covid19 #pandemic How does #COVID affect #interoperability? @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “It’s not only the data exchange; it’s your ability as a health care system to innovate.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic How close are we to adopting new and better technology and innovation? @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “Make docs happy. That is a very foreign concept for … people that are not delivering care to think about.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “We want to be able to enable the primary care physician to deliver care.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic Working doctors rather than “dictating upon them.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “I can’t sell burnout … I can sell value of care and outcomes of less cost.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “There might be an increase in overconsumption of care.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic What benefits might unlimited primary care offer? @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “Everything you do for the patient should have a clear value to them.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “What type of technology can provide this missing link for your particular health care system?” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic “We need more evidence in data around the delivery of this technology-enabled service.” @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic Care management vs consumerism. @ysolad and Rahul Dubey discuss #healthcare delivery and reimbursement from the #payer and #provider perspectives. #healthcarepodcast #podcast #digitalhealth #covid19 #pandemic

Check out my bestselling book, The Carnivore Code:  www.thecarnivorecodebook.com Dr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there. Dr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management and mental health.   Time stamps: 10:25 Start of podcast 11:05 Tro’s story. 26:10 How Coronavirus shows people will change their behaviors for their health.  27:45 The problem with mainstream health advice. 33:45 Metabolic dysfunction of americans. 34:35 Importance of Satiety. 39:10 Does the type of carbohydrate you eat matter? 40:45 Do some people have a carbohydrate threshold? 47:45 Clearing your liver glycogen and ketosis. 48:59 Tro’s perspective on Coronavirus.  53:45 Paul’s perspective on downsides of social distancing. 56:48 Metabolic dysfunction and Coronavirus.  1:01:20 How Coronavirus exposes how metabolically unhealthy we are. 1:07:30 Should we begin reopening society?  1:11:08 Daily prevalence of mortality (Portugal) 1:13:25 How do we protect the old from Coronavirus?  1:17:35 What type of testing does Tro do with his patients? 1:18:50 Coronavirus antibodies/can you get reinfected after recovering? 1:22:00 estimates of the uninfected rate (Iceland) 1:24:40 Why isn't diabetes not called a pandemic? 1:26:00 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. (study) 1:30:00 Diabetes and influenza. 1:31:20 Diet apathy. 1:35:45 Where to find Tro online. 1:36:55 What is the most radical thing Tro has done recently.     BluBlox: www.blubox.com use the code CarnivoreMD for 15% off your order   Ancestral Supplements https://ancestralsupplements.com/ Code SALADINOMD on the shopify site to receive 10% off.   White Oak Pastures: Use the code CARNIVOREMD at www.whiteoakpastures.com for 10% off your first order!   JOOVV: www.joovv.com/paul To subscribe to my newsletter visit: carnivoremd.com   My contact information:   Book: www.thecarnivorecodebook.com   PATREON: https://www.patreon.com/paulsaladinomd   SOCIAL MEDIA  Instagram: @carnivoremd Website: carnivoremd.com Twitter:@carnivoremd  Facebook: Paul Saladino MD email: drpaul@carnivoremd.com

This one was powerful. From a quick bash of purchased influencers to a discussion about appetite management, my interview with Dr. Tro Kalayjian of the Low Carb MD Podcast was as entertaining as it was enlightening. I hope you find it valuable! EducationDr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there.ResearchDr. Tro has also published case reports on Achalasia, Binge Eating Disorder and Food Addiction. He has worked on several clinical research projects, including; a study that demonstrated the statistically significant impact of a novel hospital-based safety initiative, a systemic review comparing treatment options for neuropathic pain, a clinical trial that established a relationship between post-exercise ABI and a positive nuclear stress test.Therapeutic FocusDr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management and mental health.MentionedJoin The Inner Circledefiningdadbod.com/innercircleLatest NON-COVID Content: TRUFIT SERIESdefiningdadbod.com/trufitMeal Planning Tooldefiningdadbod.com/shop/mealplanJump Start YOUR Fitness Journeydefiningdadbod.com/shop/jumpstartMore Dr. TroWebsite - https://www.doctortro.com/Low Carb MD Podcast - hhttps://podcasts.apple.com/us/podcast/low-carb-md-podcast/id1441557261Twitter - https://twitter.com/DoctorTroBecome a supporter of this podcast: https://www.spreaker.com/podcast/faithful-fitness-by-better-daily--5150768/support.

This one was powerful. From a quick bash of purchased influencers to a discussion about appetite management, my interview with Dr. Tro Kalayjian of the Low Carb MD Podcast was as entertaining as it was enlightening. I hope you find it valuable! EducationDr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there.ResearchDr. Tro has also published case reports on Achalasia, Binge Eating Disorder and Food Addiction. He has worked on several clinical research projects, including; a study that demonstrated the statistically significant impact of a novel hospital-based safety initiative, a systemic review comparing treatment options for neuropathic pain, a clinical trial that established a relationship between post-exercise ABI and a positive nuclear stress test.Therapeutic FocusDr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management and mental health.MentionedJoin The Inner Circledefiningdadbod.com/innercircleLatest NON-COVID Content: TRUFIT SERIESdefiningdadbod.com/trufitMeal Planning Tooldefiningdadbod.com/shop/mealplanJump Start YOUR Fitness Journeydefiningdadbod.com/shop/jumpstartMore Dr. TroWebsite - https://www.doctortro.com/Low Carb MD Podcast - hhttps://podcasts.apple.com/us/podcast/low-carb-md-podcast/id1441557261Twitter - https://twitter.com/DoctorTro

This one was powerful. From a quick bash of purchased influencers to a discussion about appetite management, my interview with Dr. Tro Kalayjian of the Low Carb MD Podcast was as entertaining as it was enlightening. I hope you find it valuable! EducationDr. Tro is a board-certified Internal Medicine & Obesity Medicine Physician. Dr. Tro received his medical degree from Touro Medical College and completed his Internal Medicine Residency in the Yale New Haven Health System at Greenwich Hospital, serving as Chief Medical Resident during his time there.ResearchDr. Tro has also published case reports on Achalasia, Binge Eating Disorder and Food Addiction. He has worked on several clinical research projects, including; a study that demonstrated the statistically significant impact of a novel hospital-based safety initiative, a systemic review comparing treatment options for neuropathic pain, a clinical trial that established a relationship between post-exercise ABI and a positive nuclear stress test.Therapeutic FocusDr. Tro's therapeutic focus includes diabetes, obesity, hypertension, hyperlipidemia, metabolic syndrome and PCOS. Dr. Tro's approach begins with intensive lifestyle changes including diet, exercise, improved sleep hygiene, as well as stress management and mental health.MentionedJoin The Inner Circledefiningdadbod.com/innercircleLatest NON-COVID Content: TRUFIT SERIESdefiningdadbod.com/trufitMeal Planning Tooldefiningdadbod.com/shop/mealplanJump Start YOUR Fitness Journeydefiningdadbod.com/shop/jumpstartMore Dr. TroWebsite - https://www.doctortro.com/Low Carb MD Podcast - hhttps://podcasts.apple.com/us/podcast/low-carb-md-podcast/id1441557261Twitter - https://twitter.com/DoctorTro

An interview with Dr. Steven Choi, Head Quality Officer of the Yale New Haven Health System.

In this episode of Fireside Chat, we sit down with Marna Borgstrom, CEO of Yale New Haven Health System. Marna talks to us about improving patient care, the price of healthcare, and academic medicine.

Dr Carolyn Lam: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and it's editors. I'm Dr Carolyn Lam, Associate Editor from the National Heart center and Duke National University of Singapore. Dr Greg Hundley: And I'm associate editor, Dr Greg Hundley, from VCU Health, the Pauley Heart Center, in Richmond, Virginia. Well Carolyn, our feature discussion, are results from the Odyssey study and they're presented by Professor Wouter Jukema from Leiden University Medical Center, regarding the relationship between ultra-low LDL levels in both ischemic and hemorrhagic stroke. The study really seeks to answer the question related to concerns that ultra-low LDL levels, less than 15 milligrams per deciliter, in patients treated for ischemic heart disease could increase the risk of hemorrhagic stroke, but more to come on that intriguing question. Carolyn, how about your first paper? Dr Carolyn Lam: It's from doctors Condorelli and Kallikourdis from Humanitas Clinical and Research Center and Institute of Genetic and Biomedical Research respectively in Rozzano Milan in Italy. Now, these authors used single cell RNA sequencing to map the cardiac immune composition in the standard Murine non ischemic pressure overload heart failure model. They then integrated their findings using multi parameter flow cytometry, immunohistochemistry and tissue clarification immunofluorescence in both the mouse and the human. And they found that despite the absence of infectious agents or an autoimmune trigger, induction of disease led to immune activation that involved far more cell types than previously thought. And that included neutrophils, B cells, natural killer cells, and mast cells. And this really opens up the field of cardio immunology to further investigation using toolkits that have already been developed to study these immune subsets. Dr Greg Hundley: Ah, so Carolyn, do they have any specific examples? Dr Carolyn Lam: Hmm, indeed they did. They found that activation lead to up regulation of key subset specific molecules such as pro inflammatory cytokine onco statin M in pro-inflammatory macrophages, and PD1 in T regulatory cells. Now these are significant because they may help to explain clinical findings such as the refractivity of heart failure patients to anti TNF therapy and cardio toxicity during anti PD1 cancer immunotherapy respectively, for the more these subset specific molecules may become useful targets for the diagnosis or therapy of heart failure. Dr Greg Hundley: Oh, beautiful. Well Carolyn, my next article is from Ambarish Pandey from University of Texas Southwestern Medical Center and it's entitled Incorporation of Biomarkers into Risk Assessment for Allocation of any Hypertensive Medication, According to the 2017 ACC, AHA High Blood Pressure Guidelines, a Pooled Cohort Analysis. Dr Carolyn Lam: So I suppose asking does consideration of troponin or BNP inform cardiovascular risk in those with hypertension? Dr Greg Hundley: Great question Carolyn. So in this study, the authors included participant level data from 12,987 participants across three cohort studies, ERIC, the Dallas Heart Study and MESA. And they were pooled excluding individuals with prevalent cardiovascular disease and those taking antihypertension medications at baseline. Participants were analyzed according to blood pressure treatment group from the 2017 ACC AHA Blood Pressure Guideline and those with high blood pressure, 120 to 159 millimeters of mercury, were further stratified by biomarker status. Dr Carolyn Lam: Okay. So what did they find Greg? Dr Greg Hundley: Participants with elevated blood pressure or hypertension, not recommended for any hypertensive medication with versus without either elevated high sensitivity, cardiac troponin T or N terminal pro BNP, had a 10-year cardiovascular incidence rate of 11% and 4.6%, with a 10-year number needed to treat to prevent one event for intensive blood pressure lowering of 36 and 85 individuals respectively. In addition, among participants with stage one or stage two hypertension recommended for antihypertensive medication with a blood pressure less than 160 over a hundred millimeters of mercury, those with versus without an elevated biomarker had a 10-year cardiovascular incidence rate of 15.1% and 7.9% with a 10-year number needed to treat, to prevent one event of 26 individuals and 49 individuals respectively. Dr Carolyn Lam: Wow, Greg, those are impressive numbers. So does this mean we should be checking biomarkers in everyone? Dr Greg Hundley: Great question again Carolyn. These results suggest that a biomarker based approach to cardiovascular risk assessment may help identify high risk individuals with elevated blood pressure or stage one hypertension who are currently not recommended for any hypertensive medication, according to the 2017 ACC AHA Blood Pressure Guideline, but who may benefit from blood pressure lowering therapy. And it seems the more we research blood pressure measures, the more we learn regarding individualizing targets for blood pressure lowering. Dr Carolyn Lam: Very interesting Greg. Thanks. So my next paper sought to understand to what extent do drug costs, which are potentially actionable factors, contribute to medication non-adherence? A very interesting and relevant question, and this is from Dr Nasir from Yale New Haven Health System and colleagues who identified more than 14,000 US adults with a reported history of atherosclerotic cardiovascular disease in the national health interview survey from 2013 to 2017. Now participants were considered to have experienced cost related non-adherence if in the preceding 12 months they reported either skipping doses to save money or taking less medication to save money or delaying filling a prescription to save money. And they used survey analysis to obtain national estimates. Dr Greg Hundley: Okay, Carolyn. So what did they find? Dr Carolyn Lam: Listen to this. So they found that one in eight patients with atherosclerotic cardiovascular disease reported non-adherence with medications due to cost, representing nearly 1.5 million estimated patients missing doses, 1.6 million taking lower than prescribed doses and 1.9 million intentionally delaying a medication fill to save costs, all in the United States. Patients less than 65 years of age, had a three fold higher rate of medication noncompliance due to cost, with significantly higher rates in women and among patients from low income families and those without health insurance. Now the take home message I think is that the removal of financial barriers to accessing medications, particularly among vulnerable patient groups, may help improve adherence to essential therapies to reduce atherosclerotic cardiovascular disease, morbidity and mortality. Dr Greg Hundley: Great paper, Carolyn. We've got a couple other articles in this issue. Let's just run through so our listeners get a synopsis. So Dr Javed Butler from University of Mississippi Medical Center has a nice white paper regarding heart failure endpoints in cardiovascular outcome trials of SGLT2 inhibitors in patients with type two diabetes. Dr Brahmajee Nallamothu in a perspective piece, discusses issues related to the legal prosecution of stent cases and the 70/30 rule. Remember Carolyn, the 70/30 rule, the operator may say a stenosis is 70% of an intracoronary luminal narrowing, but in review, others seem to think it's less than 30% and often these cases are prosecuted for performing coronary artery interventions on these lesions, but what Dr Nallamothu argues is perhaps, these definitions are really related to how that stenosis was measured. Are you taking approximately dilated segment or a distantly dilating segment as your reference point? Really interesting perspective piece. The next article is from Dr Prateeti Khazanie at the University of Colorado in Denver and provides an on my mind piece with Dr Mark Drazner regarding ethical issues that arise during cardiac transplant allocation process. They review some of the pitfalls associated with current physician subjective assessments used for heart transplants in the United States. Dr Neil Kay presents another EKG challenge related to T, a new wave alternans and consumption of alcohol in association with combinations of antiarrhythmic drugs. Dr Dipan Shah from Houston Methodist provides new data in a letter, a research letter, regarding the association of extracellular volume fraction and MRI measure of interstitial fibrosis in the setting of chronic mitral regurgitation. And finally, Carolyn, Dr Nirvik Pal and colleagues write a letter referring to an earlier publication related to LVAD adverse outcomes and cardiac transplantation. Well, shall we move on to that feature discussion? Dr Carolyn Lam: Yeah, let's do that, Greg. Dr Greg Hundley: Welcome everyone to our feature discussion and we're very excited today to have Dr Wouter Jukema from Leiden University Medical Center who's going to tell us about the utility of PCSK9 inhibitors on the impact of both ischemic and hemorrhagic stroke. A large study that comes from the Odyssey study. Welter, we are so glad that you're with us this morning, afternoon, evening, wherever you may be in the world. Could you tell us, what were the thoughts behind putting this study together? Dr Wouter Jukema: As we all know that patients with acute coronary syndromes, ACS, are at an increased risk for a subsequent stroke. And we also do know that lowering of atherogenic lipoproteins, including LDL cholesterol of course, reduces the risk of ischemic stroke in chronic atherosclerotic cardiovascular disease or recent ACS. However, concerns have been raised about very low LDL cholesterol levels and the potential risk and increased risk of hemorrhagic stroke. So the effect of lipid lowering by PCSK9 inhibition, both ischemic and hemorrhagic stroke is actually not fully determined. So what we therefore did to better investigate this is that in the obviously outcomes trial, the main publication was of course in New England Journal of Medicine already, we did a pre-specified analysis. We was designed to assess the effect of LRO come up on the ischemic as well as on the hemorrhagic stroke in patients with a recent ACS in obviously outcomes, all patients had a recent ACS and we have hypothesized that for patients treated with LRO come up that would be one, A, a reduction in risk of ischemic stroke, B, without an increase in hemorrhagic stroke. And we also hypothesize that the results would be irrespective of baseline LDL cholesterol and the history of cerebral vascular disease. So that was our background and objectives and we investigated this in urology outcomes trial a huge, huge trial. If you may all recall post ACS patients one to 12 months post ACS, they all had a run in period two to 16 weeks of high intensity or maximum tolerated dose of atorvastatin or rosuvastatin, and then you had to meet certain lipids criteria and then you were randomized to LRO come up circuitously every two weeks or placebo. And of course all the patients and investigators were blinded to lipid levels and treatment location. So this was a design. Dr Greg Hundley: Wouter that was a fantastic description of why we're studying this particular series of issues as both ischemic and hemorrhagic strokes. Tell us a little bit about your study results? Dr Wouter Jukema: We looked at the entire population of the Odyssey outcomes trial. This is almost 19000 patients and then we looked if they had a history of prior cerebral vascular disease or we have no history of cerebral vascular disease. The majority, almost 18000 did not have a history of cerebral vascular disease and over 900 did have a history of cerebral vascular disease. And we've also looked at our baseline LDL cholesterol levels. Well, if you can of course, be sure we appreciate people with history of cerebral vascular disease or way out, there are a different study population. So that's of course what you may expect anyway. And that's what we saw. But regardless if you have the history of a vascular disease or you didn't have that, we saw a reduction of any stroke and actually it was 28% reduction of any stroke, which is quite impressive, in my opinion, as highly significant with a P value of point 0.05 and then afterwards of course, we tried to split it in ischemic stroke and hemorrhagic strokes. So as I told you, any stroke was reduced with 28% and if you then look at ischemic stroke, it was 27%. Also significant at the P value of 0.01. And then of course, the big question, what would happen with hemorrhagic stroke. And actually this was numerically less also in the LRO come up group. So there was not only a reduction in any stroke, but also in ischemic stroke. But also in hemorrhagic stroke, but this was 17% and then of course you are in the low numbers. So the ischemic ratio for hemorrhagic stroke was 0.83 in favor of LRO come up. And of course that by itself is not significant to the low numbers, but numerically there were less hemorrhagic strokes on top of that, there were less ischemic strokes and that was, I think a very reassuring finding. And the interesting part is that these results were more or less independent. If you have a history of cerebral vascular disease are not, so people without a price were benefiting and with a price were benefiting. And it was also statistically independent of your baseline LDL cholesterol level. So the results were basically the same. If you had a baseline LDL starting below 80 between 80 and 100 and over 100 the results were the same. LRO come up was always better than placebo. If you look at the data, you could see that it was perhaps doing slightly even better if you had a slightly higher cholesterol from the start, which is conceivable. But the formal test returned 80 did not say show any difference. So you could say the beneficial effect of other LRO come up on stroke in post ACA patients is independent of your history of cerebral vascular disease, is independent of your baseline LDL. LRO come up is just better for ischemic strokes as well as for hemorrhagic strokes at least there was no sign. Never mind add to that, we did even go one step further and we looked at the risk of hemorrhagic stroke in relation to the HG LDL cholesterol level. So not your baseline LDL cholesterol level, but the achieved LDL cholesterol level in the LRO come up group because there you find the, of course very low numbers and we divided them and below 25 milligrams per deciliter, which we could continue really low between 25 to 15, 15 to 17 over 17 and the numbers of hemorrhagic strokes were exactly the same, always 0.1, 0.2, 0.3%. So very low. And it was certainly not the case that they do very low numbers. We saw more hemorrhagic strokes. So this is again very reassuring data. So even at very low levels of LDL during the trial. Of course we should realize that this trial is of course only a medium duration of two per date, but we didn't see more erratic strokes. So in my opinion, this is very reassuring data. Dr Greg Hundley: Very good. I loved all that analysis of subgroups. I want to ask you one quick subgroup question. Was there any difference in outcomes related to gender or age? Dr Wouter Jukema: As far as we could see there was no differential effect in gender nor in age. Of course you should realize that in very advanced age, of course the numbers get small and if you then start dividing them again in the history of stroke or not, then of course the numbers will get low. But in general there is no age or gender difference. Dr Greg Hundley: Fantastic. So where do you think, does this field progress from here and what do you think will be the next study that we need related to PCSK9 inhibitors and adverse effects? Dr Wouter Jukema: I think we have shown now that patients with a recent ACS and dyslipidemia, despite incentive therapy, they do benefit from the PCSK9 LRO Come up, which is reflected by a decrease in the risk of stroke. You should of course realize that this is a post ACS population, so it was not targeted in a post stroke population. This is a atherosclerotic disease population, so the results are applying for an atherosclerotic population of course, many people that have a stroke in the past may have and also from embolic processes from a FIP or whatsoever, and those results may be the same but may of course they may also be different. So that situation was not tested here. This is a atherosclerotic post ACS population. Of course you may be interested in what would happen with strokes in an embolic population with a FIP and that would of course be a very nice trial to do as well. But then you have to do an entirely new trial. And some of these trials are of course underway, but I cannot, with my publication circulation, I cannot provide you with the answer. Dr Greg Hundley: Well listeners, we've had a great discussion on our feature article today from Dr Wouter Jukema from Leiden university medical center and really some important insights related to PCSK9 inhibitors and the fact in this study, a large study, a sub study from Odyssey that indicates really no increase incidents of both hemorrhagic or ischemic stroke in patients that receive these agents and had previously sustained acute coronary syndromes. I want to wish you all a great week and on the half of Carolyn and myself. Hope to see you next week. Take care now. This program is copyright American heart association 2019.  

Melissa Scott, Senior Managing Director with GlassRatner's health care industry group, speaks to Jennifer Willcox, Vice President of Legal Services, Yale New Haven Health System, and Rebecca Matthews, Wiggin and Dana LLP, about their presentation at AHLA's 2019 Annual Meeting in Boston regarding innovative collaborations between hospitals and health centers. Sponsored by GlassRatner.

Dr. Michael Apkon ’02 is the CEO of Tufts Medical Center and Floating Hospital for Children. He is interviewed by Keval Desai ’20, a joint degree MBA/MD student in his first year at Yale SOM. Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center and the Floating Hospital for Children, is a physician executive and physician scientist. In that capacity, he leads a 415-bed hospital staffed by 6,000 employees, scientists, medical staff, students, and volunteers with a $1 billion budget. Prior to coming to Tufts Medical Center, Apkon was the president and CEO at The Hospital for Sick Children (SickKids) in Toronto, Ontario, recognized as one of the world’s top children’s hospitals and Canada’s most research-intensive hospital. Apkon has also held senior executive and academic roles at top academic health science centers, including senior vice president for medical affairs and the chief medical officer for the Children’s Hospital of Philadelphia (CHOP) as well as roles at Yale University School of Medicine and Yale New Haven Health System, including being the vice president for performance management at the Yale New Haven Health System and the vice president/executive director leading Yale New Haven Children’s Hospital. He has held faculty positions at the University of Toronto, the University of Pennsylvania, and Yale University’s School of Medicine and School of Management.  Keval Desai ’20 is a first-year MBA student pursuing a joint degree with the Yale School of Medicine. He has completed the core clinical clerkship year and sub-internship. Prior to coming to Yale, Keval pursued a bachelor of science from the University of California, San Diego and studied comparative philosophy and religion in India. Keval hopes to combine his passion for medicine and training at SOM to pursue a career in health systems administration, looking for ways to make health care more efficient and affordable. Keval was born in India and grew up in Northern California.  Show Notes

Dr. Tro Kalayjian is a board-certified internal medicine physician and weight loss expert who has passionately devoted his life to bringing good health and wellness to everyone. Dr. Kalayjian delivers an interesting and useful overview of his methods to achieve weight loss and health improvement. Dr. Kalayjian has a medical degree from Touro Medical College and he completed his internal medicine residency in the Yale New Haven Health System at Greenwich Hospital where he served as a chief medical resident. A prolific publisher, Dr. Kalayjian has released a wide variety of important case reports and findings in the areas of binge eating disorder, food addiction, and achalasia— a rare disorder that makes it very difficult for foods and liquids to pass into the stomach. His therapeutic focus includes obesity, hypertension, diabetes, hyperlipidemia, and metabolic syndrome. Dr. Kalayjian recommends a combination of intensive lifestyle changes including diet, exercise, stress management, and mental health care to many of his patients seeking improved health. Dr. Kalayjian discusses the emotional and metabolic issues that could make weight loss more challenging for some. He recounts stories of patients who have run into difficulty losing weight even after undergoing dramatic procedures such as gastric bypass surgery, etc. As Kalayjian explains, there are many reasons why weight loss can be difficult and he works with patients that have diverse issues that present challenges for them. Kalayjian provides a basic overview of his four-month program, starting with comprehensive lab work, an initial ninety-minute session and weekly follow-ups for up to eight weeks. Additionally, lab work is redone to assess changes, and subsequent consultations follow. Kalayjian monitors weight, body fat, blood pressure, body/fat/water mass, heart rate, glucose and more, to get a complete picture of a patient's body and how it is functioning. He states his average weight loss for the program is about 35 pounds, with extremes of as little as four pounds lost, and 120 pounds as the maximum lost. Kalayjian discusses how his process first begins with figuring out what is causing the obesity in a patient, and only after reaching his conclusion can he then get them started on an appropriate diet, such as low fat, or low carb, ketogenic, etc., that will yield the results they are seeking. And while his patients are working toward their goal, Kalayjian also offers opportunities for them to socialize in various ways with others who are also seeking weight loss, to create a sense of community, one that provides support. He details the process as patients move into months three and four that may involve some fasting, dietary restrictions, time-restricted feeding, and exercise. Additionally, he talks about the problems people have when they plateau and some options, such as intermittent fasting and hunger assessments that may help them get past it and begin losing weight again. The diet and nutrition expert details the important role that metabolism plays in weight loss. And he explains how some of the TV show weight loss programs that push fast weight loss have permanently damaged participants' metabolism by approaching weight loss the wrong way. As he states, weight loss is a process and he advises one pound per week for most patients, to ensure a safe, effective, long-term strategy that can provide lasting results. Kalayjian explains that the vast array of ‘eat more, move less,' ‘count calorie,' and other conventional programs and ideas really do not work for most people. Kalayjian's goal is to provide a better way for his patients to find success in their weight loss plan, to lose the weight and keep it off for life. He recounts how his wife offered encouragement that nudged him to embark on his own personal weight loss journey, an experience that has helped him to better understand how to help others. He takes his patients' journeys very personally and feels that if they fail, he has failed, so he makes it a point of never letting them fail, even if they have specific metabolic difficulties that may make their path to success a bit of a longer one. Kalayjian explains that diet and nutrition have been proven to not only impact weight loss, but also many other diseases and pre-disease conditions, and he is incredibly passionate about helping patients improve their health and be well.

Marna Borgstrom, CEO of Yale New Haven Health System, discusses strategies to grow and develop talent by creating a great employer brand. Takeaways for healthcare executives include tactics for building a leadership team that executes well by creating shared values.

Dr. Miriam Alexander is a nationally recognized expert on preventive medicine. In this episode, she discusses why most people don't get much benefit from their annual medical exams and explains how you can approach you and your family's health more proactively. Dr. Alexander has more than 25 years experience as an occupational medicine physician, and has overseen employee health for tens of thousands of employees at organizations including Bethlehem Steel, McCormick & Co., and the Yale New Haven Health System. She is also a past president of the American College of Preventive Medicine and a former faculty member of the Johns Hopkins Bloomberg School of Public Health. She currently serves as medical director for employee health at Life Bridge Health in Baltimore and as a clinical advisor to ICMed.

Starting her career as a clinical nurse in the Pediatric ICU at Yale New Haven Health System, MPRO’S Vice President of Clinical Operations, Jacqueline Rosenblatt, emphasizes both her educational achievements (Masters and PhD) and her circuitous journey into information technology in this podcast.  She discusses how challenges given to her by the CIO of a major health system spurred her subsequent lifelong love affair with health information technology and informatics. Jacquie shares insight on: Her journey outside and inside the technology field Overcoming discriminatory preconceptions of stereotypical nurse roles The importance of being a lifelong learner and egalitarian leader How to be, and stay, positive as a leader MPRO can be found at www.mpro.org and Jacqueline can be contacted at jrosen@mpro.org. Make sure to check us out on online at www.divatechtalk.com, on Twitter @divatechtalks, and on Facebook at https://www.facebook.com/divatechalk.

Michael Lee Stallard is the author of "Connection Culture: The Competitive Advantage of Shared Identity, Empathy, and Understanding at Work." He is co-founder and president of E Pluribus Partners and a respected and recognized expert on the human connection aspects of leadership and culture. He speaks, teaches, coaches and consults for clients including General Electric, Google, M.D. Anderson Cancer Center, NASA, Texas Christian University, U.S. Department of Treasury and Yale New Haven Health System. In their interview, we discuss what Bono and U2 can teach leaders about making a great work culture.

YALE NEW HAVEN HEALTH SYSTEM CASE STUDY With an increase in cyber attacks across industries, and in particular healthcare with medical-related identity theft accounting for 43 percent of all identity thefts reported in the United States last year according to the Identity Theft Resource Center, managing risk has never been more pressing for organizations. With risk growing daily and the consequences -- both in terms of data loss, patient and employee confidence and potential fines -- looming large, one healthcare organization that takes cyber security seriously is Yale New Haven Health System. Steve Bartolotta, who heads the health system's information security and risk management program talks about the challenges facing organizations today across verticals and what measures he recommends taking.  In this podcast with securitycurrent's Vic Wheatman, Bartolotta talks about the actual tools he uses to support Yale New Haven's risk management system and what he has gained.